Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’

THURSDAY, Aug. 3, 2023 (HealthDay News) -- A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk for severe stomach problems.
The lawsuit seeks "very significant" but unspecified compensation from the makers of both Ozempic and Mounjaro, said attorney Paul Pennock of the Orlando, Florida.-based firm Morgan & Morgan.
Pennock filed the lawsuit Wednesday on behalf of Jaclyn Bjorklund, 44, NBC News reported. The lawsuit against Novo Nordisk and Eli Lilly claims Bjorklund was "severely injured" after taking the two diabetes drugs. Pennock said she is suffering "persistent" vomiting and severe gastroparesis.
The glucagon-like peptide 1 (GLP-1) agonists slow food's movement and have been found to cause some gastrointestinal issues in clinical trials. Those are listed as side effects on the drug labels. Both Ozempic and Mounjaro have the phrase "delays gastric emptying" on their prescribing information, though they do not specifically use the word "gastroparesis," NBC News reported.
A U.S. Food and Drug Administration spokeswoman said it was unclear whether the GLP-1 medications contribute to gastroparesis. "If newly identified safety signals are identified, the FDA will determine what actions are appropriate after a thorough review of the body of evidence," spokeswoman Chanapa Tantibanchachai said in a statement, NBC News reported.
Eli Lilly did not respond to an NBC News request for comment, and a Novo Nordisk spokeswoman said the company was unaware of the lawsuit. "Patient safety is of utmost importance to Novo Nordisk," said spokeswoman Natalia Salomao. "We recommend patients take these medications for their approved indications and under the supervision of a health care professional."
Related Posts
El vapeo aumenta el riesgo de coágulos sanguíneos y daña a las arterias pequeñas, según un estudio
MARTES, 7 de septiembre de 2021 (HealthDay News) -- Los cigarrillos electrónicos...
Una agencia federal sopesa una prohibición de las estufas de gas debido a problemas de salud
MARTES, 10 de enero de 2023 (HealthDay News) -- Las estufas de gas podrían...
Rates of CV Risk Factors, Disease Projected to Rise by 2060
TUESDAY, Aug. 2, 2022 (HealthDay News) -- The projected rates of cardiovascular...
Rubella Elimination Likely to Be Achievable in All Countries
FRIDAY, Sept. 30, 2022 (HealthDay News) -- Rubella elimination is likely to be...